Literature DB >> 24955781

Prognostic impact of pretransplantation hyperferritinemia in adults undergoing allogeneic hematopoietic SCT: a meta-analysis.

Z Wang1, M Jia1, H Zhao1, Y Cheng1, Z Luo1, Y Chen1, X Xu1, Y Tang1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24955781     DOI： 10.1038/bmt.2014.127

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  10 in total

1.  Serum ferritin and disease status at transplantation predict the outcome of allo-SCT in patients with AML or myelodysplastic syndrome.

Authors:  T Tachibana; H Takasaki; M Tanaka; A Maruta; R Hyo; Y Ishigatsubo; H Kanamori
Journal:  Bone Marrow Transplant       Date:  2010-04-12       Impact factor: 5.483

2.  Pretransplant serum ferritin has a prognostic influence on allogeneic transplant regardless of disease risk.

Authors:  Takayoshi Tachibana; Masatsugu Tanaka; Ayumi Numata; Hirotaka Takasaki; Satomi Ito; Rika Ohshima; Maki Hagihara; Etsuko Yamazaki; Naoto Tomita; Katsumichi Fujimaki; Jun Taguchi; Rika Sakai; Hiroyuki Fujita; Shin Fujisawa; Atsuo Maruta; Yoshiaki Ishigatsubo; Heiwa Kanamori
Journal:  Leuk Lymphoma       Date:  2011-10-24

3.  A prognostic score with pretransplant serum ferritin and disease status predicts outcome following reduced-intensity SCT.

Authors:  M Tanaka; T Tachibana; A Numata; H Takasaki; K Matsumoto; A Maruta; Y Ishigatsubo; H Kanamori
Journal:  Bone Marrow Transplant       Date:  2011-06-06       Impact factor: 5.483

4.  Hyperferritinemia in stem cell transplantation.

Authors:  Philippe Armand
Journal:  Biol Blood Marrow Transplant       Date:  2013-01-04       Impact factor: 5.742

5.  Beta blockade during and after myocardial infarction: an overview of the randomized trials.

Authors:  S Yusuf; R Peto; J Lewis; R Collins; P Sleight
Journal:  Prog Cardiovasc Dis       Date:  1985 Mar-Apr       Impact factor: 8.194

6.  Risk factors for fungal pulmonary infections in hematopoietic stem cell transplantation recipients: the role of iron overload.

Authors:  E Ozyilmaz; M Aydogdu; G Sucak; S Z Aki; Z N Ozkurt; Z A Yegin; N Kokturk
Journal:  Bone Marrow Transplant       Date:  2010-02-01       Impact factor: 5.483

Review 7.  The significance of ferritin in cancer: anti-oxidation, inflammation and tumorigenesis.

Authors:  Ahmed A Alkhateeb; James R Connor
Journal:  Biochim Biophys Acta       Date:  2013-07-25

8.  The oral iron chelator deferasirox might improve survival in allogeneic hematopoietic cell transplant (alloHSCT) recipients with transfusional iron overload.

Authors:  Serdar Sivgin; Suleyman Baldane; Gulsah Akyol; Muzaffer Keklik; Leylagül Kaynar; Fatih Kurnaz; Cigdem Pala; Gokmen Zararsiz; Mustafa Cetin; Bulent Eser; Ali Unal
Journal:  Transfus Apher Sci       Date:  2013-08-02       Impact factor: 1.764

9.  The transplant iron score as a predictor of stem cell transplant survival.

Authors:  Jonathan A Storey; Rebecca F Connor; Zachary T Lewis; David Hurd; Gregory Pomper; Yi K Keung; Manisha Grover; James Lovato; Suzy V Torti; Frank M Torti; István Molnár
Journal:  J Hematol Oncol       Date:  2009-10-24       Impact factor: 17.388

10.  Effect of iron overload and iron-chelating therapy on allogeneic hematopoietic SCT in children.

Authors:  J W Lee; H J Kang; E K Kim; H Kim; H Y Shin; H S Ahn
Journal:  Bone Marrow Transplant       Date:  2009-04-27       Impact factor: 5.483
  10 in total
  4 in total

1.  ATG vs thiotepa with busulfan and cyclophosphamide in matched-related bone marrow transplantation for thalassemia.

Authors:  Lawrence Faulkner; Cornelio Uderzo; Sadaf Khalid; Priya Marwah; Rajpreet Soni; Naila Yaqub; Samina Amanat; Itrat Fatima; Sarah Khan Gilani; Tatheer Zahra; Stalin Ramprakash; Lallindra Gooneratne; Ruwangi Dissanayake; Senani Williams; Wasantha Rathnayake; Reshma Srinivas; Amit Sedai; Ankita Kumari; Lailith Parmar; Rakesh Dhanya; Rajat Kumar Agarwal
Journal:  Blood Adv       Date:  2017-05-11

Review 2.  Current Review of Iron Overload and Related Complications in Hematopoietic Stem Cell Transplantation.

Authors:  Erden Atilla; Selami K Toprak; Taner Demirer
Journal:  Turk J Haematol       Date:  2016-12-12       Impact factor: 1.831

3.  Improved survival outcomes and restoration of graft-vs-leukemia effect by deferasirox after allogeneic stem cell transplantation in acute myeloid leukemia.

Authors:  Byung-Sik Cho; Young-Woo Jeon; A-Reum Hahn; Tai-Hyang Lee; Sung-Soo Park; Jae-Ho Yoon; Sung-Eun Lee; Ki-Seong Eom; Yoo-Jin Kim; Seok Lee; Chang-Ki Min; Seok-Goo Cho; Jong-Wook Lee; Woo-Sung Min; Hee-Je Kim
Journal:  Cancer Med       Date:  2019-01-24       Impact factor: 4.452

4.  Early transplantation-related mortality after allogeneic hematopoietic cell transplantation in patients with acute leukemia.

Authors:  Seom Gim Kong; Seri Jeong; Sangjin Lee; Jee-Yeong Jeong; Da Jung Kim; Ho Sup Lee
Journal:  BMC Cancer       Date:  2021-02-18       Impact factor: 4.430
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.